RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3074% below fair value

$5.38+0.10 (+1.89%)

Close on Nov 12, 2026Market cap $223.77MP/E –Yield –

RxSight operating margin

Operating margin is operating income as a percentage of revenue.

RxSight's operating margin for the twelve months ending Jun 30, 2026 was -43.2%. For fiscal 2025 it was -35.8%, against -26.3% the year before. The highest annual figure on record is -26.3% in fiscal 2024.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-35.8%	−9.5
FY2024	Dec 31, 2024	-26.3%	+29.9
FY2023	Dec 31, 2023	-56.2%	+73.0
FY2022	Dec 31, 2022	-129.2%	+104.4
FY2021	Dec 31, 2021	-233.6%	+7.6
FY2020	Dec 31, 2020	-241.3%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	-40.8%	+0.8
Q1 FY2026	Mar 31, 2026	-57.7%	−29.5
Q4 FY2025	Dec 31, 2025	-34.8%	−13.3
Q3 FY2025	Sep 30, 2025	-40.1%	−14.0
Q2 FY2025	Jun 30, 2025	-41.6%	−17.7
Q1 FY2025	Mar 31, 2025	-28.2%	+8.0
Q4 FY2024	Dec 31, 2024	-21.5%	+16.5
Q3 FY2024	Sep 30, 2024	-26.1%	+30.2
Q2 FY2024	Jun 30, 2024	-23.9%	+41.6
Q1 FY2024	Mar 31, 2024	-36.2%	+38.7
Q4 FY2023	Dec 31, 2023	-38.0%	+55.2
Q3 FY2023	Sep 30, 2023	-56.4%	+70.1
Q2 FY2023	Jun 30, 2023	-65.5%	+73.5
Q1 FY2023	Mar 31, 2023	-74.9%	+110.5
Q4 FY2022	Dec 31, 2022	-93.2%	+80.8
Q3 FY2022	Sep 30, 2022	-126.5%	+100.1
Q2 FY2022	Jun 30, 2022	-139.0%	+144.4
Q1 FY2022	Mar 31, 2022	-185.4%	+134.2
Q4 FY2021	Dec 31, 2021	-174.0%	−5.1
Q3 FY2021	Sep 30, 2021	-226.6%	−13.0
Q2 FY2021	Jun 30, 2021	-283.4%	+42.1
Q1 FY2021	Mar 31, 2021	-319.6%	–
Q4 FY2020	Dec 31, 2020	-168.9%	–
Q3 FY2020	Sep 30, 2020	-213.6%	–
Q2 FY2020	Jun 30, 2020	-325.5%	–